Local therapy treatment conditions for oligometastatic non-small cell lung cancer

Standard treatments for patients with metastatic non-small cell lung cancer (NSCLC) include palliative chemotherapy and radiotherapy, but with limited survival rates. With the development of improved immunotherapy and targeted therapy, NSCLC prognoses have significantly improved. In recent years, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Suli, Sun, Qian, Cai, Feng, Li, Hui, Zhou, Yufu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773544/
https://www.ncbi.nlm.nih.gov/pubmed/36568167
http://dx.doi.org/10.3389/fonc.2022.1028132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773544/
https://www.ncbi.nlm.nih.gov/pubmed/36568167
http://dx.doi.org/10.3389/fonc.2022.1028132

Ejemplares similares